Form D · Pharmaceuticals
SPECTRUM PHARMACEUTICALS INC
Henderson, NV · CIK 0000831547
Offering snapshot reported Apr 28, 2016 · SEC filing
- Reported sold
- $3M Offering amount: $3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2016 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Jul 31, 2013 | Initial | $27,500,000 | No comparison | 4 | SEC filing |
| May 31, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-262249
Source: Form D, filed Apr 28, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lee F. Allen | Executive |
| Raymond W. Cohen | Director |
| Gilles R. Gagnon | Director |
| Kurt A. Gustafson | Executive |
| Joseph K. Keller | Executive |
| Stuart M. Krasner | Director |
| Stuart M. Krassner | Director |
| Luigi Lenaz | Director |
| Anthony E. Maida | Director |
| Rajesh C. Shrotriya | Director, Executive |
| Joseph W. Turgeon | Executive |
| Dolatrai Vyas | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11500 S. Eastern Ave., Suite 240
Henderson, NV, 89052
Henderson, NV, 89052